Human Volunteers

19 registered clinical trials studyying Human Volunteers.

Status	Trial	Sponsor	Phase
Completed	Bio-Equivalence Study of Budesonide Prolonged-release Tablets 9 Mg In Healthy Human Adult Subjects NCT05519514	Abbott	Phase 1
Completed	A Study to Determine the Safety and Immunogenicity of the Candidate Influenza Vaccine MVA-NP+M1 NCT03277456	Barinthus Biotherapeutics	EARLY_Phase 1
Completed	A Study to Examine the Effect of Omeprazole, Famotidine, and an Acidic Beverage on the Pharmacokinetics of Ent NCT02922933	Syndax Pharmaceuticals	Phase 1
Completed	Study to Determine the Effect of the Timing of a Meal on the Pharmacokinetics of Entinostat NCT02922946	Syndax Pharmaceuticals	Phase 1
Completed	Study of BMN 673, a PARP Inhibitor, in Healthy Adult Male Volunteers NCT01776437	Pfizer	Phase 1
Completed	An Open-label, Bioequivalence Study to Evaluate LEV Administered as a 45-min Intravenous Infusion and Same Dos NCT01618903	UCB Pharma	Phase 1
Completed	A Randomized, Double-blind, Pharmacokinetics Study to Assess Safety, Tolerability of Levetiracetam 45 Minutes NCT01618877	UCB Pharma	Phase 1
Completed	A Study To Estimate The Effect Of Ketoconazole On The Pharmacokinetics Of Pf-04937319 In Healthy Subjects NCT01468714	Pfizer	Phase 1
Completed	Nutrition Beverage Tolerance Study NCT01464385	Abbott Nutrition	Phase 2
Completed	In Vivo Optical Spectroscopy Monitoring in a New Model of Muscular Compartment Syndrome NCT01452425	Université Catholique de Louvain	Phase 1
Completed	Effects of Micro-dose and Low-dose Recombinant Human Erythropoietin on Mitochondrial Function and Cognitive Pe NCT03093506	Bispebjerg Hospital	EARLY_Phase 1
Completed	Breath Test for Chemicals (Volatile Organic Compounds) NCT01437033	National Cancer Institute (NCI)	—
Completed	Drug-Drug Interaction Study Of Effect Of PF-03882845 On Simvastatin Pharmacokinetics NCT01445860	Pfizer	Phase 1
Completed	TMC278-TiDP6-C152: A Study to Assess the Effects of TMC278 and Efavirenz (EFV) on the QT/QTc Interval (Heart C NCT00744809	Tibotec Pharmaceuticals, Ireland	Phase 1
Unknown	Bioequivalence of Phenazopyridine HCl in Healthy Volunteers NCT00743977	Universal Enterprises	N/A
Completed	The Effects of a Novel NMDA NR2B-Subtype Selective Antagonist, EVT 101, on Brain Function NCT00526968	Evotec Neurosciences GmbH	Phase 1
Completed	Effect of NGX-4010 on ENFD and Sensory Function NCT00254449	NeurogesX	Phase 1
Completed	Minimal Erythema Dose of UV-B in Normal Population of Taiwan NCT00166933	National Taiwan University Hospital	—
Completed	A Drug Interaction Study of the Pharmacokinetics of Topiramate and FLUNARIZINE When Given Together or Separate NCT00752466	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Phase 1